These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31709579)

  • 1. Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.
    Foss FM; Horwitz SM; Civallero M; Bellei M; Marcheselli L; Kim WS; Cabrera ME; Dlouhy I; Nagler A; Advani RH; Pesce EA; Ko YH; Montoto S; Chiattone C; Moskowitz A; Spina M; Cesaretti M; Biasoli I; Federico M
    Am J Hematol; 2020 Feb; 95(2):151-155. PubMed ID: 31709579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
    Kharfan-Dabaja MA; Kumar A; Ayala E; Hamadani M; Reimer P; Gisselbrecht C; d'Amore F; Jantunen E; Ishida T; Bazarbachi A; Foss F; Advani R; Fenske TS; Lazarus HM; Friedberg JW; Aljurf M; Sokol L; Tobinai K; Tse E; Burns LJ; Chavez JC; Reddy NM; Suzuki R; Ahmed S; Nademanee A; Mohty M; Gopal AK; Fanale MA; Pro B; Moskowitz AJ; Sureda A; Perales MA; Carpenter PA; Savani BN
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1826-1838. PubMed ID: 28797780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.
    Jantunen E; Boumendil A; Finel H; Luan JJ; Johnson P; Rambaldi A; Haynes A; Duchosal MA; Bethge W; Biron P; Carlson K; Craddock C; Rudin C; Finke J; Salles G; Kroschinsky F; Sureda A; Dreger P;
    Blood; 2013 Mar; 121(13):2529-32. PubMed ID: 23361910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.
    Prochazka V; Faber E; Raida L; Papajik T; Vondrakova J; Rusinakova Z; Kucerova L; Myslivecek M; Indrak K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):63-9. PubMed ID: 21475380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful therapy for enteropathy-associated peripheral T-cell lymphoma using high-dose polychemotherapy and autologous hematopoietic stem cell transplantation].
    Vorob'ev VI; Kravchenko SK; Kovrigina AM
    Ter Arkh; 2013; 85(7):79-83. PubMed ID: 24137952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.
    Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M
    J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
    Sieniawski M; Angamuthu N; Boyd K; Chasty R; Davies J; Forsyth P; Jack F; Lyons S; Mounter P; Revell P; Proctor SJ; Lennard AL
    Blood; 2010 May; 115(18):3664-70. PubMed ID: 20197551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience.
    Bojanini L; Jiang L; Tun AJ; Ayala E; Menke DM; Hoppe B; Kharfan-Dabaja MA; Tun HW; Alhaj Moustafa M
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):106-112.e1. PubMed ID: 33160933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
    Prochazka V; Faber E; Raida L; Vondrakova J; Kucerova L; Jarosova M; Indrak K; Papajik T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):63-6. PubMed ID: 19365529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aggressive peripheral T-cell lymphomas: 2015.
    Armitage JO
    Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
    Yam C; Landsburg DJ; Nead KT; Lin X; Mato AR; Svoboda J; Loren AW; Frey NV; Stadtmauer EA; Porter DL; Schuster SJ; Nasta SD
    Am J Hematol; 2016 Jul; 91(7):672-6. PubMed ID: 27012928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis.
    El-Asmar J; Reljic T; Ayala E; Hamadani M; Nishihori T; Kumar A; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2016 May; 22(5):802-14. PubMed ID: 26713431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.
    Blystad AK; Enblad G; Kvaløy S; Berglund A; Delabie J; Holte H; Carlson K; Kvalheim G; Bengtsson M; Hagberg H
    Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.
    Przybylski GK; Wu H; Macon WR; Finan J; Leonard DG; Felgar RE; DiGiuseppe JA; Nowell PC; Swerdlow SH; Kadin ME; Wasik MA; Salhany KE
    J Mol Diagn; 2000 Feb; 2(1):11-9. PubMed ID: 11272897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.
    Sharaiha RZ; Lebwohl B; Reimers L; Bhagat G; Green PH; Neugut AI
    Cancer; 2012 Aug; 118(15):3786-92. PubMed ID: 22169928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell transplantation for peripheral T-cell lymphomas.
    Jantunen E; D'Amore F
    Leuk Lymphoma; 2004 Mar; 45(3):441-6. PubMed ID: 15160904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma.
    Jeon Y; Yoon SE; Cho J; Kim SJ; Kim WS
    Ann Hematol; 2023 Jul; 102(7):1867-1877. PubMed ID: 37188978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.
    Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M
    Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.